BFI CO., LLC sold 0.9% of their position (520.00 shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $23.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/14/2018ACC: 0001144204-18-049581
-520.00
Net shares
Net seller
$23.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 30.52K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
100.0%
9/12/2018
30K→60K
Class A Common Stock
Direct
Shares
−520.00
Price / share
$45.04
Trade value
$23.42K
% of position
0.9%
9/12/2018
60K→59.48K
Total
Net shares
+29.48K
Net value
-$23.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/12/2018 | C · Conversion | +30K | — | — | 100.0% | 30K | 60K |
| Class A Common Stock Direct | 9/12/2018 | S · Sale | −520.00 | $45.04 | $23.42K | 0.9% | 60K | 59.48K |
| Total | +29.48K | -$23.42K | ||||||
Derivative Transactions1
Class B Common Stock
Direct
Converts to
Class A Common Stock
30K shares
Shares
−30K
Strike price
0
Held after
20.17M
Exercisable
—
9/12/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Common Stock Direct | Class A Common Stock30K shares | 9/12/2018 | C · Conversion | −30K | 0 | — | 20.17M |